🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed as a 3-part trial to evaluate the safety of a novel ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01348100
Treatments Being Tested
Evaluate the clinical outcome of two switching strategies to iloperidone tr...
Status
Completed
Location
Birmingham Psychiatry Pharmaceutical Studies, Inc.
Start Date
2010-08
Trial ID
NCT01207414
Treatments Being Tested
To evaluate the safety and tolerability of iloperidone in adolescent patien...
Status
Recruiting
Location
Vanda Investigational Site
Start Date
2023-05-24
Trial ID
NCT05648591
Treatments Being Tested
to inspect relevant pharmacokinetic parameters and relative exploitation de...
Status
Unknown
Location
The first affiliated hospital of zhengzhou university.
Start Date
2017-11-17
Trial ID
NCT03420534
Treatments Being Tested
The purpose of the study is to determine whether motivation/reward deficits...
Status
Completed
Location
Kings College London
Start Date
2017-12-21
Trial ID
NCT03319953
Treatments Being Tested
Tolerability, undertstanding of the action of the drug in the body, and und...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01495169
Treatments Being Tested
This 3-part dose titration study will assess elpipodect safety, tolerabilit...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-05
Trial ID
NCT02181803
Treatments Being Tested
The purpose of this study is to determine whether Iloperidone is effective ...
Status
Completed
Location
Vanda Investigative Site
Start Date
2011-02
Trial ID
NCT01291511
Treatments Being Tested
This 4-panel study will evaluate the safety, tolerability, pharmacokinetics...
Status
Completed
Location
California Clinical Trials ( Site 0001)
Start Date
2018-06-20
Trial ID
NCT03565068
Treatments Being Tested
Iloperidone is an atypical antipsychotic drug, FDA-approved for the acute t...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2012-04
Trial ID
NCT01464229
Treatments Being Tested